Login / Signup

Injured recipients of low-titer group O whole blood have similar clinical outcomes compared to recipients of conventional component therapy: A single-center, retrospective study.

Mark H YazerAndrew FreemanIan M HarroldVincent AntoMatthew D NealDarrell J TriulziJason L SperryJansen N Seheult
Published in: Transfusion (2021)
In both matched analyses, administration of a median of four LTOWB units did not result in a different frequency of major clinical outcomes including mortality.
Keyphrases
  • kidney transplantation
  • cardiovascular events
  • risk factors
  • stem cells
  • coronary artery disease
  • bone marrow
  • cell therapy